Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of glaucoma or ocular hypertension in both eyes~* Patient requires IOP-lowering drug in both eyes~Exclusion Criteria:~* Uncontrolled medical conditions~* Ocular seasonal allergies within the past 2 years

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).